PAPER Tang H, Mao X, Xie L, Greenberg DA, Jin K
SEARCH RESULTS
331388 RESULTS
PAPER Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, Schroeter ML, Schröder J, Schönknecht P
Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Neurosci Lett. 2013 Feb 8;534:12-7. PubMed: 23182881PAPER Li G, Bekris LM, Leong L, Steinbart EJ, Shofer JB, Crane PK, Larson EB, Peskind ER, Bird TD, Yu CE
TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ɛ3/ɛ3.
Alzheimers Dement. 2012 Nov 22; PubMed: 23183136PAPER Maillet D, Rajah MN
Association between prefrontal activity and volume change in prefrontal and medial temporal lobes in aging and dementia: A review.
Ageing Res Rev. 2012 Nov 24;12(2):479-489. PubMed: 23183352PAPER Attar A, Ripoli C, Riccardi E, Maiti P, Li Puma DD, Liu T, Hayes J, Jones MR, Lichti-Kaiser K, Yang F, Gale GD, Tseng CH, Tan M, Xie CW, Straudinger JL, Klärner FG, Schrader T, Frautschy SA, Grassi C, Bitan G
Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers.
Brain. 2012 Dec;135(Pt 12):3735-48. PubMed: 23183235PAPER Kimura N, Nakama H, Nakamura K, Aso Y, Kumamoto T
Effect of white matter lesions on brain perfusion in Alzheimer's disease.
Dement Geriatr Cogn Disord. 2012;34(3-4):256-61. PubMed: 23183589PAPER Avdesh A, Chen M, Martin-Iverson MT, Mondal A, Ong D, Rainey-Smith S, Taddei K, Lardelli M, Groth DM, Verdile G, Martins RN
Regular care and maintenance of a zebrafish (Danio rerio) laboratory: an introduction.
J Vis Exp. 2012;(69):e4196. PubMed: 23183629PAPER Oboh G, Agunloye OM, Akinyemi AJ, Ademiluyi AO, Adefegha SA
Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer's disease and some pro-oxidant induced oxidative stress in rats' brain-in vitro.
Neurochem Res. 2013 Feb;38(2):413-9. PubMed: 23184188PAPER Hofmann W
[Guideline-based diagnosis of dementia etiology].
Z Gerontol Geriatr. 2012 Dec;45(8):761-71; quiz 772-3. PubMed: 23184302PAPER Liu D, Chen W, Tian Y, He S, Zheng W, Sun J, Wang Z, Jiang X
A highly sensitive gold-nanoparticle-based assay for acetylcholinesterase in cerebrospinal fluid of transgenic mice with Alzheimer's disease.
Adv Healthc Mater. 2012 Jan 11;1(1):90-5. PubMed: 23184691PAPER Govindarajan N, Rao P, Burkhardt S, Sananbenesi F, Schlüter OM, Bradke F, Lu J, Fischer A
Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease.
EMBO Mol Med. 2013 Jan;5(1):52-63. PubMed: 23184605PAPER Geng J, Li M, Wu L, Chen C, Qu X
Mesoporous silica nanoparticle-based H2O2 responsive controlled-release system used for Alzheimer's disease treatment.
Adv Healthc Mater. 2012 May;1(3):332-6. PubMed: 23184750PAPER Milanesi L, Sheynis T, Xue WF, Orlova EV, Hellewell AL, Jelinek R, Hewitt EW, Radford SE, Saibil HR
Direct three-dimensional visualization of membrane disruption by amyloid fibrils.
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20455-60. PubMed: 23184970PAPER Wiethoff S, Zhour A, Schöls L, Fischer MD
Retinal nerve fibre layer loss in hereditary spastic paraplegias is restricted to complex phenotypes.
BMC Neurol. 2012;12:143. PubMed: 23176075PAPER de Aquino RA, Modolo LV, Alves RB, de Fátima A
Design of New Drugs for the Treatment of Alzheimers Disease based on Tacrine Structure.
Curr Drug Targets. 2012 Nov 21; PubMed: 23176115Current Filters
No filters selected